Brinker Capital Investments’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-13,083
| Closed | -$1.08M | – | 1787 |
|
|
2024
Q2 | $1.08M | Sell |
13,083
-6,534
| -33% | -$538K | 0.01% | 957 |
|
|
2024
Q1 | $1.71M | Sell |
19,617
-568
| -3% | -$49.6K | 0.02% | 732 |
|
|
2023
Q4 | $2M | Sell |
20,185
-2,150
| -10% | -$213K | 0.02% | 630 |
|
|
2023
Q3 | $1.98M | Buy |
22,335
+3,785
| +20% | +$335K | 0.02% | 614 |
|
|
2023
Q2 | $1.61M | Sell |
18,550
-1,029
| -5% | -$89.2K | 0.02% | 748 |
|
|
2023
Q1 | $1.9M | Buy |
19,579
+438
| +2% | +$42.6K | 0.02% | 615 |
|
|
2022
Q4 | $1.98M | Sell |
19,141
-1,883
| -9% | -$195K | 0.04% | 486 |
|
|
2022
Q3 | $1.78M | Buy |
21,024
+56
| +0.3% | +$4.75K | 0.04% | 499 |
|
|
2022
Q2 | $1.74M | Buy |
20,968
+4,424
| +27% | +$367K | 0.03% | 529 |
|
|
2022
Q1 | $1.28M | Buy |
16,544
+4,797
| +41% | +$370K | 0.02% | 705 |
|
|
2021
Q4 | $1.04M | Sell |
11,747
-14,626
| -55% | -$1.29M | 0.02% | 808 |
|
|
2021
Q3 | $2.2M | Hold |
26,373
| – | – | 0.03% | 524 |
|
|
2021
Q2 | $2.2M | Buy |
26,373
+4,521
| +21% | +$377K | 0.03% | 577 |
|
|
2021
Q1 | $1.65M | Sell |
21,852
-21,934
| -50% | -$1.66M | 0.02% | 566 |
|
|
2020
Q4 | $3.84M | Buy |
43,786
+25,097
| +134% | +$2.2M | 0.06% | 394 |
|
|
2020
Q3 | $1.42M | Buy |
+18,689
| New | +$1.42M | 0.02% | 582 |
|
|
2019
Q4 | – | Sell |
-77
| Closed | -$5K | – | 806 |
|
|
2019
Q3 | $5K | Buy |
+77
| New | +$5K | ﹤0.01% | 628 |
|